We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-2.25%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.08B
AUM Growth
-$442M
Cap. Flow
+$54.8M
Cap. Flow %
0.77%
Top 10 Hldgs %
30.94%
Holding
2,554
New
55
Increased
1,499
Reduced
409
Closed
77

Sector Composition

Rank Sector Weight
1 Financials 28.61%
2 Technology 12.91%
3 Healthcare 9.07%
4 Industrials 8.27%
5 Consumer Discretionary 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCRH icon
1976
QCR Holdings
QCRH
$1.75B
$173K ﹤0.01%
3,855
DNLI icon
1977
Denali Therapeutics
DNLI
$3.97B
$173K ﹤0.01%
+8,769
New +$180K
LORL
1978
DELISTED
Loral Space and Communications, Inc.
LORL
$172K ﹤0.01%
4,138
FOSL icon
1979
Fossil Group
FOSL
$330M
$172K ﹤0.01%
13,557
+4,970
+58% +$54.9K
SPWR
1980
DELISTED
SunPower Corporation Common Stock
SPWR
$172K ﹤0.01%
32,940
BAS
1981
DELISTED
Basis Energy Services, Inc.
BAS
$172K ﹤0.01%
11,911
+5,222
+78% +$101K
FRGI
1982
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$172K ﹤0.01%
9,294
+702
+8% +$13.2K
HAWK
1983
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$172K ﹤0.01%
3,844
-13,616
-78% -$594K
GRC icon
1984
Gorman-Rupp
GRC
$2.11B
$172K ﹤0.01%
5,871
CTT
1985
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$172K ﹤0.01%
13,770
+14
+0.1% +$181
CTRL
1986
DELISTED
Control4 Corporation
CTRL
$172K ﹤0.01%
7,991
GFF icon
1987
Griffon
GFF
$4.8B
$172K ﹤0.01%
9,404
-23
-0.2% -$453
BOLD
1988
DELISTED
Audentes Therapeutics, Inc
BOLD
$172K ﹤0.01%
5,708
VICR icon
1989
Vicor
VICR
$10.4B
$171K ﹤0.01%
5,985
MLAB icon
1990
Mesa Laboratories
MLAB
$633M
$171K ﹤0.01%
1,151
GTHX
1991
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$170K ﹤0.01%
+4,594
New +$123K
HSKA
1992
DELISTED
Heska Corp
HSKA
$169K ﹤0.01%
2,143
IR icon
1993
Ingersoll Rand
IR
$32.7B
$169K ﹤0.01%
5,518
+668
+14% +$22.3K
MSBI icon
1994
Midland States Bancorp
MSBI
$698M
$169K ﹤0.01%
5,363
MDGL icon
1995
Madrigal Pharmaceuticals
MDGL
$11.7B
$169K ﹤0.01%
1,449
MCRI icon
1996
Monarch Casino & Resort
MCRI
$2.2B
$169K ﹤0.01%
3,992
HTB
1997
HomeTrust Bancshares
HTB
$837M
$169K ﹤0.01%
6,473
CTRN icon
1998
Citi Trends
CTRN
$621M
$169K ﹤0.01%
5,452
ABTX
1999
DELISTED
Allegiance Bancshares
ABTX
$167K ﹤0.01%
4,275
ANIP icon
2000
ANI Pharmaceuticals
ANIP
$1.72B
$167K ﹤0.01%
2,872

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q1 2018 Portfolio in Review

As of Q1 2018, Metropolitan Life Insurance Company (MetLife) held 2,554 positions worth $7.08B, down 5.9% from $7.53B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q1 2018 filing shows 55 new, 1,499 increased, 409 reduced and 77 closed positions. Its largest new stake was Boardwalk Pipeline Partners: 168,156 shares worth $1.71M. The largest sale was iShares MSCI EAFE ETF, an estimated $9.07M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q1 2018 buy was Boardwalk Pipeline Partners: 168,156 shares worth $1.71M.
  • Metropolitan Life Insurance Company (MetLife) added most to Bank of America in Q1 2018, an estimated $21.6M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q1 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $9.07M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Encompass Health in Q1 2018, selling an estimated $2.77M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 31% of its $7.08B portfolio in Q1 2018.
  • Metropolitan Life Insurance Company (MetLife) opened 55 new positions and closed 77 in Q1 2018.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 5.9% quarter-over-quarter to $7.08B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2018, filed 15 May 2018.